Amidase and use thereof for producing 3-aminocarboxylic acid esters

Abstract

Process for producing optically active 3-aminocarboxylic acid ester compounds of general Formula I, and the ammonium salts thereof, in which R 1 stands for alkyl, alkoxyalkyl, alkenyl, cycloalkyl, heterocycloalkyl, aryl, or hetaryl, and R 2 stands for alkyl, cycloalkyl or aryl, in which an enantiomeric mixture of a simply N-acylated 3-aminocarboxylic acid ester of general formula (I.b), in which R 1 and R 2 have the meanings given above and R 3 stands for hydrogen, alkyl, cycloalkyl or aryl, is submitted to an enantioselective deacylation by adding a polypeptide according to claim 1.

1 - 8 . (canceled) 
     
     
         9 . A polypeptide with amidase activity, selected from
 a) polypeptide comprising an amino acid sequence according to SEQ ID NO: 2, and   b) polypeptide comprising an amino acid sequence that has at least 96% identity with SEQ ID NO:2.   
     
     
         10 . A polypeptide with amidase activity, selected from
 a) polypeptide comprising an amino acid sequence according to SEQ ID NO: 4, and   b) polypeptide comprising an amino acid sequence that has at least 80% identity with SEQ ID NO:4.   
     
     
         11 . A process for producing optically active 3-aminocarboxylic acid ester compounds of general Formula I, and the ammonium salts thereof, 
       
         
           
           
               
               
           
         
         wherein 
         R 1  stands for alkyl, alkoxyalkyl, alkenyl, cycloalkyl, heterocycloalkyl, aryl, or hetaryl, and 
         R 2  stands for alkyl, cycloalkyl or aryl, 
         in which an enantiomeric mixture of a simply N-acylated 3-aminocarboxylic acid ester of general formula (I.b), 
       
       
         
           
           
               
               
           
         
         in which R 1  and R 2  have the meanings given above and R 3  stands for hydrogen, alkyl, cycloalkyl or aryl, is submitted to an enantioselective deacylation by adding a polypeptide according to  claim 9 . 
       
     
     
         12 . A process for producing optically active 3-aminocarboxylic acid ester compounds of general Formula I, and the ammonium salts thereof, 
       
         
           
           
               
               
           
         
         wherein 
         R 1  stands for alkyl, alkoxyalkyl, alkenyl, cycloalkyl, heterocycloalkyl, aryl, or hetaryl, and 
         R 2  stands for alkyl, cycloalkyl or aryl, 
         in which an enantiomeric mixture of a simply N-acylated 3-aminocarboxylic acid ester of general formula (I.b), 
       
       
         
           
           
               
               
           
         
         in which R 1  and R 2  have the meanings given above and R 3  stands for hydrogen, alkyl, cycloalkyl or aryl, is submitted to an enantioselective deacylation by adding a polypeptide according to  claim 10 . 
       
     
     
         13 . A process for producing optically active 3-aminocarboxylic acid ester compounds of general Formula I′, and derivatives thereof, 
       
         
           
           
               
               
           
         
         in which 
         R 1  stands for alkyl, alkoxyalkyl, alkenyl, cycloalkyl, heterocycloalkyl, aryl, or hetaryl, and 
         R 2  stands for hydrogen, a cation equivalent M + , alkyl, cycloalkyl or aryl, in which
 a) a β-ketoester of general Formula I.1 
 
       
       
         
           
           
               
               
           
         
         
           
             in which R 1  and R 2  have the meanings given above, is reacted 
             a 1) with at least one carboxylic acid amide of formula R 3 —C(O)NH 2 , in which R 3  has the meaning given above, in the presence of an amidation catalyst, or 
             a 2) with ammonia and then with a carboxylic acid derivative of formula R 3 —C(O)X, in which X stands for halogen or a residue of formula OC(O)R 4 , in which R 4  has the meaning given above for R 3 ,
 obtaining the corresponding N-acylated, α-β-unsaturated (Z)-3-aminocarboxylic acid ester, of general formula (I.a), 
 
           
         
       
       
         
           
           
               
               
           
         
         
           
             
               in which R 1 , R 2  and R 3  have the meanings given above, 
             
           
           b) the enamide (I.a) obtained in this reaction is submitted to a hydrogenation, obtaining an enantiomeric mixture of simply N-acylated β-aminocarboxylic acid esters of general formula (I.b), 
         
       
       
         
           
           
               
               
           
         
         
           
             in which R 1 , R 2  and R 3  have the meanings given above, 
           
           c) the enantiomeric mixture of compounds I.b obtained in the hydrogenation is submitted to an enantioselective deacylation by adding a polypeptide according to  claim 9  and the resultant ammonium salt of a 3-aminocarboxylic acid ester, enriched with respect to a stereoisomer, is isolated, and 
           d) optionally the ammonium salt isolated is converted to the 3-aminocarboxylic acid ester, and 
           e) optionally the 3-aminocarboxylic acid ester is converted to the free 3-aminocarboxylic acid or a salt thereof. 
         
       
     
     
         14 . The process according to  claim 11 , wherein a β-ketoester of Formula I.1 is reacted with at least one carboxylic acid amide of formula R 3 —C(O)NH 2 , in the presence of an amidation catalyst, with removal of the reaction water, to a 3-aminocarboxylic acid ester of Formula I.a. 
     
     
         15 . The process according to  claim 12 , wherein a β-ketoester of Formula I.1 is reacted with at least one carboxylic acid amide of formula R 3 —C(O)NH 2 , in the presence of an amidation catalyst, with removal of the reaction water, to a 3-aminocarboxylic acid ester of Formula I.a. 
     
     
         16 . The process according to  claim 9 , wherein the deacylation is carried out in aqueous buffer as reaction medium. 
     
     
         17 . The process according to  claim 10 , wherein the deacylation is carried out in aqueous buffer as reaction medium. 
     
     
         18 . The process according to  claim 13 , wherein the hydrogenation b) is carried out in the presence of a hydrogenation catalyst, which comprises at least one complex of a transition metal of groups 8 to 11 of the periodic table of the elements and comprises, as ligand, at least one chiral, phosphorus atom-containing compound. 
     
     
         19 . The process according to  claim 11 , wherein R 1  stands for phenyl and R 2  and R 3  have the meanings stated in  claim 10 . 
     
     
         20 . The process according to  claim 11 , wherein R 1  stands for phenyl and R 2  and R 3  have the meanings stated in  claim 10 .